Clinical Trial Update: COVID-19 ANtibody Responses in Cystic Fibrosis: CAR-CF

View source ↗

Summary

This clinical trial update reports the completion of a study evaluating antibody responses to COVID-19 in people with cystic fibrosis treated with CAR-CF.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• CAR-CF

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: COVID-19, Cystic Fibrosis | Status: COMPLETED